{"ticker": {"uuid": "70fcb57b-2abb-4f8d-9bab-83a2eb539af4", "symbol": "NTI", "name": "Neurotech International Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Neurotech International (ASX:NTI) Rises 12.5% \u2014 What Is Driving the Paediatric Health Technology Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPX1o5dmllMk5fdlI4VmxSMndZSFlJRVFDRXhyNEMyOTgtV0t0ZFU1UWdsQTZJTzgxRkhMaVdEc1A5TWRSWXllX291aTkxd0E1WXV6emM5cEJyN3Z5VzEyT2thM1dlTS1feENZTGtSM3g0Q1FuV2twb0lMcHA4Y1dzRm0tWXV4WTBjYzVxbHJ6N21xVjFWbWhvZzBpYW15YmNfcHQ5RWxBeUxYcEdydHhtZ19mUlJEMElTb3dEMEk4Mzh2dmRtckNLRzN6dG8wR2s?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T05:11:00+00:00", "published_display": "14 Jul 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International (ASX:NTI) Gets FDA Green Light to Start US Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPNFZsa3VPOTBWc1prM0pPbzZlVTI2ZERXZGxFNWdsWXVESHdhbXhoUnhTOUg5NWVaSXNiYnJLeXA2VWJ2WlVWUXJMOXl2dUsxSWxHSzNQZVZUZVVRQVFlV2RSMXdEaVlyM1JzYXdXTG5iU0haVDJta1JlaklXOGQ5UVhNZlZPUnZkNlo4cHowZEN0ZnRTM2QxSFBsV0t6ejFjODFwb1hUZUVvZHYtRGc?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T03:42:00+00:00", "published_display": "14 Jul 2026 03:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International Ltd (ASX: NTI) Shares Rally as Investors Monitor Clinical Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQzR6XzVBSjRFeENGVnZWXy01QnFhUVBsRmFvZF9keW9lRUUybExYeEFZLWFYcjMxYnBLUG9JYWFHME9fSGtsNzFwQjRVUHlPbU44a0gtZWFIeUozUERtWFdvOVRXUFg4Sm83NkRvNVF6aEdNajM4Y2pGWW0zYVpzbEpMZ3hPdHVHbVlqYXRXTFJ5Tnhuc3dUUm1RMHh3bVdWMWM2NkZUZEVZNURqNHhKRnZsZjF3ckZxUURnS2ZkcUNkYXFy?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T02:48:00+00:00", "published_display": "14 Jul 2026 02:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Check: Neurotech shares soar 30% on US cannabis trial breakthrough", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQMGdwOWVoMms0LV9UVG9HTF9sMXFpcVFmb0tMdzBPNmJSNU85dWhXcDJzX2hGazhlVkI2Y1p0MDA1NXNoSEJ2QUNUb1M1TDk2SXZlUE92a2IzZnc3c1ZyMjlBWkxid2xicXJuZXJoTGx4V3hMdUxEUDZNTVlZWHJ2MEZkWXNBR29BWlpUOFJOVHRZYklEZXBfTWVGMTV5cXFaUjdVajl3MA?oc=5", "source_name": "Stockhead", "published_at": "2026-07-14T02:47:42+00:00", "published_display": "14 Jul 2026 02:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International issues 19.5M unlisted options", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOdVFCSzBiSUJ1TklVdG9DdFpqb0lfUmRBMm8tOTN1SmpGczZKa3JkeGZ3enUzcjRNejdKQTk2ZEw3dWZfZGdMVXpTM0g4Wm1WRW1MbEpVbEJsNG1YVDhZc2R2VE1pQVg2SGFNaVdXNHRYN191N2lQc21DbnhpemEzeXNRX2Y1WHB4a016ZmROX3dNc0k?oc=5", "source_name": "grafa.com", "published_at": "2026-07-14T00:36:30+00:00", "published_display": "14 Jul 2026 00:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech (ASX:NTI) clears FDA IND for NTI164 and the partnering conversation just got real", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPZTltUFppVkVXVW82WWpSQnc1eXc2TGUyT3RzeURSay1vRnRpbTBUNkw3OWkxRnBaS2JEVHVPZ2tDN3lQZzRDVkswUnJzR0J0dmppQklIRU9kaHV1TlFFYWk1Sl9JRk14azVaVlA2U3NiUGVYS2plazFMamltaUg5OUtpTQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-07-14T00:35:19+00:00", "published_display": "14 Jul 2026 00:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International Announces Proposed Issue of Securities to Enhance Capital Structure", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNcm1xcUo0MVExYUlTa20zVU5VTWpZRHpCVTYxNzU4VUw5MVRJVS1HSHpkcUNIeEhXcFRoR25Sbm1sNkxpcWI4YUc4YWd0cldZd3E5bTdkZXlCSTdvMHdFWDdpSHRQVkYtNVF0aFRTTWlYaFJDamF5THRYMEhSZHlJVTc0ZmZUSHAwbDdwX0dTQmR0eVBMdl9MZVc2SkNEazBBRl9UYm5TNmx2WXdfYlA3c01tSThjUGVYTXgyTnZWRkVaVEs5R0N3RDByZzhVZw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T11:40:26+00:00", "published_display": "13 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech (ASX:NTI) Strengthens NTI164 Position with US Patent Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVE9uRlJLXzRBZGJMS2ozVGlYS0wweHZsTHBJZGR2U1llV2tJSjFVYkpoaERwNXZzUW00V19sOWJDMTl0NTJ5R0tRNWtpU0JBZER4UXZMeEJzcFZONXpTT0dCVVBaMmVXY1lRcTRUeDhucmJzTXd4MnlHbURiVGtXaGlzRWhZRThxZkRPdUlMWGtseTNJOHdyUlBqZktKMnozWEdJdTJqTlpZY2c?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T01:51:00+00:00", "published_display": "02 Jul 2026 01:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Biotech: Neurotech moves from research labs to real-world healthcare", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPd0JrQ3g3cHk4ZFVpS0ZkSlJTNlI5U3JuTHU2UjhkUU9ZaTlMMU9XOGdsY1djNHdxZTQ0NDhyTUxFYzV5LWpNMDNBV3NjX1ZwTHpuOV9GVDJmbHV0U2VyOVYzejFhLUVzUlM5c0dMQ2xwT1NOYmdIV1pKYWRvY3FVNG1TSkE1VzFUUjNiTXNXanFBYl82VE9WQ3BqbG51alNwdU9yM2dTb2lfMHhKN0hwTXpRbHJJaHpzdFB5SnhIaHlUN1FCNGVUUUlTNU5WbHFLQXROelFCcDJPQXJrMnRzR0tn?oc=5", "source_name": "Proactive financial news", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "\u2018Doesn\u2019t align\u2019: Neurotech star slams start-up tax", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "The Australian", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech opens first phase III trial site", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International (ASX: NTI) Gains 10%: Can This Biotech Micro-Cap Deliver a Breakthrough in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPNlBjbHVYZmMxRTVFZm5aV3ZFUTZaWFdqbmRGeHI0cE9QRWdtNVg1dDlLakZpbGc0WDYtZE5tMnVwSXhUZ1pXdzRUTFF3cXRlSE1OUGJGNUtrY1gyNHQ2cUVGQ0l5eWdqakQtbHVpR21CV1plUUpyVU1wemxRY2YzcVhFQVpseTN2eGdqMkU0dXpMbXdpRjExb3kyckNWV3h4eE9VamtCQ081UUt2aDNKR015QVY5ZGVoeHBLWGcyYjljRlRwbWZmcVpzNjFGWjFPMGNr?oc=5", "source_name": "Kalkine", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Neurotech International (ASX:NTI) Stock Is Moving Today: Phase 3 Autism Trial Begins at Major Hospital", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQZkNWRVR5MmQtdTEyNDhWdE93SVRYUWxuNTFGcE9qQ2gyTWdwMGhraHBwTXk1ZUtadUlENzA4MDN3VzNMYmwyc0pqdFVoY2lrZFpXLVI2Z21NRVhTeTRNdVptZ2xHaFBBQUtHVk9qd1JIWFBnUUFTdURDeC1MUEV3WFVta1dfeTdJV0U0Tk5MVTIxcGFkTlJJWGdISXQtVjM4WVpOQ3hfd0REd0RTZV9ibjJfWElrX0o1c3pFdkM1aWZuSGZhTm5kXzJ1LS10WFNZWjhvanlfaW5JajQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech\u2019s NTI164 shows strong long-term safety", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International Secures HREC Approval for Pivotal Phase 3 ASD Study of NTI164", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQzl2WjBYWF9raUdsQ010SkV1NnFvVGd1UnNGbWhoWmg5NUUzZlJBSnRWLUtPSGxtN1Zkc0ZPQ010MU9uNFVLRTVHTHlheHphRWtjaU9TZE94dHdFblpLWThFcWY5QjBiNjd0RWhuckFieDhCS2RyMlBRTmR2dUtVSUJwODIzb2N4SW9GNm1GVkhqRGZpRVFENGx0OWcyTVA5RUIzelN5MERZcDhkTmhxU2N6YjM1NkI5OGc?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-01T08:00:00+00:00", "published_display": "01 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NRFC invests $20m in AI neurotech firm Omniscient", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQW9oOGpTLUl4MkRCN3BPdERDZC1HeU0wRmhHZy13SmR2cVB6b2cyRGxOU0xMRmxIQ1g3dHRZMENnbS1kWTNFeXRhWjNZSER3MFNPTTN3cU5HelZfeWRvR09ORkt5OUlBNngtazhrWC03LTdjM1ctdmhJY0NQVlJrQUdYSlczV0lGd3hmR2FDaWlHaTQ?oc=5", "source_name": "Information Age | ACS", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Neurotech Stocks 2026 Watchlist: Slowing the Silver Tsunami", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBLSmRTOGhUTTctUHRFWTVmMmRMRmxCSjIxcUdzd2xMT0tMZU5uSHFERzdZRWtTc0FDMHNCQ19vYzVqQmNBTXZpbTFGN25Udw?oc=5", "source_name": "Exoswan Insights", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech gains FDA rare disease nod for NTI164", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Neurotech International (ASX:NTI) Rises 12.5% \u2014 What Is Driving the Paediatric Health Technology Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPX1o5dmllMk5fdlI4VmxSMndZSFlJRVFDRXhyNEMyOTgtV0t0ZFU1UWdsQTZJTzgxRkhMaVdEc1A5TWRSWXllX291aTkxd0E1WXV6emM5cEJyN3Z5VzEyT2thM1dlTS1feENZTGtSM3g0Q1FuV2twb0lMcHA4Y1dzRm0tWXV4WTBjYzVxbHJ6N21xVjFWbWhvZzBpYW15YmNfcHQ5RWxBeUxYcEdydHhtZ19mUlJEMElTb3dEMEk4Mzh2dmRtckNLRzN6dG8wR2s?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T05:11:00+00:00", "published_display": "14 Jul 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International (ASX:NTI) Gets FDA Green Light to Start US Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPNFZsa3VPOTBWc1prM0pPbzZlVTI2ZERXZGxFNWdsWXVESHdhbXhoUnhTOUg5NWVaSXNiYnJLeXA2VWJ2WlVWUXJMOXl2dUsxSWxHSzNQZVZUZVVRQVFlV2RSMXdEaVlyM1JzYXdXTG5iU0haVDJta1JlaklXOGQ5UVhNZlZPUnZkNlo4cHowZEN0ZnRTM2QxSFBsV0t6ejFjODFwb1hUZUVvZHYtRGc?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T03:42:00+00:00", "published_display": "14 Jul 2026 03:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International Ltd (ASX: NTI) Shares Rally as Investors Monitor Clinical Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQzR6XzVBSjRFeENGVnZWXy01QnFhUVBsRmFvZF9keW9lRUUybExYeEFZLWFYcjMxYnBLUG9JYWFHME9fSGtsNzFwQjRVUHlPbU44a0gtZWFIeUozUERtWFdvOVRXUFg4Sm83NkRvNVF6aEdNajM4Y2pGWW0zYVpzbEpMZ3hPdHVHbVlqYXRXTFJ5Tnhuc3dUUm1RMHh3bVdWMWM2NkZUZEVZNURqNHhKRnZsZjF3ckZxUURnS2ZkcUNkYXFy?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T02:48:00+00:00", "published_display": "14 Jul 2026 02:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Check: Neurotech shares soar 30% on US cannabis trial breakthrough", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQMGdwOWVoMms0LV9UVG9HTF9sMXFpcVFmb0tMdzBPNmJSNU85dWhXcDJzX2hGazhlVkI2Y1p0MDA1NXNoSEJ2QUNUb1M1TDk2SXZlUE92a2IzZnc3c1ZyMjlBWkxid2xicXJuZXJoTGx4V3hMdUxEUDZNTVlZWHJ2MEZkWXNBR29BWlpUOFJOVHRZYklEZXBfTWVGMTV5cXFaUjdVajl3MA?oc=5", "source_name": "Stockhead", "published_at": "2026-07-14T02:47:42+00:00", "published_display": "14 Jul 2026 02:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International issues 19.5M unlisted options", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOdVFCSzBiSUJ1TklVdG9DdFpqb0lfUmRBMm8tOTN1SmpGczZKa3JkeGZ3enUzcjRNejdKQTk2ZEw3dWZfZGdMVXpTM0g4Wm1WRW1MbEpVbEJsNG1YVDhZc2R2VE1pQVg2SGFNaVdXNHRYN191N2lQc21DbnhpemEzeXNRX2Y1WHB4a016ZmROX3dNc0k?oc=5", "source_name": "grafa.com", "published_at": "2026-07-14T00:36:30+00:00", "published_display": "14 Jul 2026 00:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech (ASX:NTI) clears FDA IND for NTI164 and the partnering conversation just got real", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPZTltUFppVkVXVW82WWpSQnc1eXc2TGUyT3RzeURSay1vRnRpbTBUNkw3OWkxRnBaS2JEVHVPZ2tDN3lQZzRDVkswUnJzR0J0dmppQklIRU9kaHV1TlFFYWk1Sl9JRk14azVaVlA2U3NiUGVYS2plazFMamltaUg5OUtpTQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-07-14T00:35:19+00:00", "published_display": "14 Jul 2026 00:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International Announces Proposed Issue of Securities to Enhance Capital Structure", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNcm1xcUo0MVExYUlTa20zVU5VTWpZRHpCVTYxNzU4VUw5MVRJVS1HSHpkcUNIeEhXcFRoR25Sbm1sNkxpcWI4YUc4YWd0cldZd3E5bTdkZXlCSTdvMHdFWDdpSHRQVkYtNVF0aFRTTWlYaFJDamF5THRYMEhSZHlJVTc0ZmZUSHAwbDdwX0dTQmR0eVBMdl9MZVc2SkNEazBBRl9UYm5TNmx2WXdfYlA3c01tSThjUGVYTXgyTnZWRkVaVEs5R0N3RDByZzhVZw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T11:40:26+00:00", "published_display": "13 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech (ASX:NTI) Strengthens NTI164 Position with US Patent Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVE9uRlJLXzRBZGJMS2ozVGlYS0wweHZsTHBJZGR2U1llV2tJSjFVYkpoaERwNXZzUW00V19sOWJDMTl0NTJ5R0tRNWtpU0JBZER4UXZMeEJzcFZONXpTT0dCVVBaMmVXY1lRcTRUeDhucmJzTXd4MnlHbURiVGtXaGlzRWhZRThxZkRPdUlMWGtseTNJOHdyUlBqZktKMnozWEdJdTJqTlpZY2c?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T01:51:00+00:00", "published_display": "02 Jul 2026 01:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Biotech: Neurotech moves from research labs to real-world healthcare", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPd0JrQ3g3cHk4ZFVpS0ZkSlJTNlI5U3JuTHU2UjhkUU9ZaTlMMU9XOGdsY1djNHdxZTQ0NDhyTUxFYzV5LWpNMDNBV3NjX1ZwTHpuOV9GVDJmbHV0U2VyOVYzejFhLUVzUlM5c0dMQ2xwT1NOYmdIV1pKYWRvY3FVNG1TSkE1VzFUUjNiTXNXanFBYl82VE9WQ3BqbG51alNwdU9yM2dTb2lfMHhKN0hwTXpRbHJJaHpzdFB5SnhIaHlUN1FCNGVUUUlTNU5WbHFLQXROelFCcDJPQXJrMnRzR0tn?oc=5", "source_name": "Proactive financial news", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "\u2018Doesn\u2019t align\u2019: Neurotech star slams start-up tax", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "The Australian", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech opens first phase III trial site", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International (ASX: NTI) Gains 10%: Can This Biotech Micro-Cap Deliver a Breakthrough in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPNlBjbHVYZmMxRTVFZm5aV3ZFUTZaWFdqbmRGeHI0cE9QRWdtNVg1dDlLakZpbGc0WDYtZE5tMnVwSXhUZ1pXdzRUTFF3cXRlSE1OUGJGNUtrY1gyNHQ2cUVGQ0l5eWdqakQtbHVpR21CV1plUUpyVU1wemxRY2YzcVhFQVpseTN2eGdqMkU0dXpMbXdpRjExb3kyckNWV3h4eE9VamtCQ081UUt2aDNKR015QVY5ZGVoeHBLWGcyYjljRlRwbWZmcVpzNjFGWjFPMGNr?oc=5", "source_name": "Kalkine", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Neurotech International (ASX:NTI) Stock Is Moving Today: Phase 3 Autism Trial Begins at Major Hospital", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQZkNWRVR5MmQtdTEyNDhWdE93SVRYUWxuNTFGcE9qQ2gyTWdwMGhraHBwTXk1ZUtadUlENzA4MDN3VzNMYmwyc0pqdFVoY2lrZFpXLVI2Z21NRVhTeTRNdVptZ2xHaFBBQUtHVk9qd1JIWFBnUUFTdURDeC1MUEV3WFVta1dfeTdJV0U0Tk5MVTIxcGFkTlJJWGdISXQtVjM4WVpOQ3hfd0REd0RTZV9ibjJfWElrX0o1c3pFdkM1aWZuSGZhTm5kXzJ1LS10WFNZWjhvanlfaW5JajQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech\u2019s NTI164 shows strong long-term safety", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech International Secures HREC Approval for Pivotal Phase 3 ASD Study of NTI164", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQzl2WjBYWF9raUdsQ010SkV1NnFvVGd1UnNGbWhoWmg5NUUzZlJBSnRWLUtPSGxtN1Zkc0ZPQ010MU9uNFVLRTVHTHlheHphRWtjaU9TZE94dHdFblpLWThFcWY5QjBiNjd0RWhuckFieDhCS2RyMlBRTmR2dUtVSUJwODIzb2N4SW9GNm1GVkhqRGZpRVFENGx0OWcyTVA5RUIzelN5MERZcDhkTmhxU2N6YjM1NkI5OGc?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-01T08:00:00+00:00", "published_display": "01 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NRFC invests $20m in AI neurotech firm Omniscient", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQW9oOGpTLUl4MkRCN3BPdERDZC1HeU0wRmhHZy13SmR2cVB6b2cyRGxOU0xMRmxIQ1g3dHRZMENnbS1kWTNFeXRhWjNZSER3MFNPTTN3cU5HelZfeWRvR09ORkt5OUlBNngtazhrWC03LTdjM1ctdmhJY0NQVlJrQUdYSlczV0lGd3hmR2FDaWlHaTQ?oc=5", "source_name": "Information Age | ACS", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Neurotech Stocks 2026 Watchlist: Slowing the Silver Tsunami", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBLSmRTOGhUTTctUHRFWTVmMmRMRmxCSjIxcUdzd2xMT0tMZU5uSHFERzdZRWtTc0FDMHNCQ19vYzVqQmNBTXZpbTFGN25Udw?oc=5", "source_name": "Exoswan Insights", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neurotech gains FDA rare disease nod for NTI164", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxOZDVDa0htVWtOQlM5c2U0LUN3cDRBZFQzaE9Oa1kzREdZMEV1UUw1Y3NpN3lhQjZLMGxYQ0x3SDduZHRDNGxUMXBYSFhCUHVIbFdzNzFqakFuZEF5Z2Q4TnBYQmw3T083RVFIWU1lS3VfV21Jek5oUWFRR3NTMXg2dlJoY1hLN095b2c2MXdUNWJQUmk0RFZwU01rVGdmbTVZUlBLcU5wcUQzeE83b29TU2poN3pRSmRWbEhzX2hSN0FaVjhRVG1IWkdFamU1QjQ3ZEVwa2tuUG1vZkxXYl9YZGlvUXhFTjZ4Y3k2cTlpblNPN3J1X1R2TDhwazNZVUNRbXfSAYcCQVVfeXFMTVg4V05xT2ZPSUtxRzZ1OVlFa2pyUnh6RGxSanlKZG1hVm9xRTBBM1hHUFM4bzNrMzI5Wl9lMVJ4S0dOQ3VzTkhOZU5YdXpCa3hQZ2FhYllJMWlrTTRnMlZaNDVsT0hPbGVQOUhHR1gycXBZemRDYlZyWlQ3bDluQUxVbmFMUUFydEUyVTZhQU01aW40QU9FZFFOZFg0VlZXY0QtV0NtLVhPNFhPZ3NkWGRpMzN3Q0lxeFY2MnBVVzk1UXFqQ09FLVIydlJTUXlYMzRwZlR2WnFHN3pQNHh5Zk55RkFtbmd4WGxsanFiemRlSmZNdWZlYTBESG5RR3Q1QVFXbUFfdVk?oc=5", "source_name": "The Australian", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 18, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 15, "score": 52, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 93, "events": [{"event": "general", "label": "Market update", "weight": 9.35, "count": 17}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.02, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 30.8, "twelve_week_move": 30.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.946304, "market_dynamics_buy_signal": false, "relative_strength": 11.843494, "fair_value_gap": -61.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 31.9218, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +30.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 7}, {"label": "The Australian", "count": 4}, {"label": "Stockhead", "count": 1}, {"label": "grafa.com", "count": 1}, {"label": "Stocks Down Under", "count": 1}, {"label": "Proactive financial news", "count": 1}, {"label": "smallcaps.com.au", "count": 1}, {"label": "Information Age | ACS", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 17}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "93/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +30.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Neurotech International (ASX:NTI) Rises 12.5% \u2014 What Is Driving the Paediatric Health Technology Stock?"}], "updated_at": "2026-07-18T01:25:52.705392+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}